Published in
Elsevier, Cancer Genetics and Cytogenetics, 2(199), p. 139-142
DOI: 10.1016/j.cancergencyto.2010.02.008
Links
Tools
Sustained molecular remissions are achievable with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia and additional cytogenetic clonal evolution
Journal article published in 2010 by
Lorenzo Falchi 
,
Giovanna Rege-Cambrin,
Carmen Fava,
Emilio Donti,
Debora Luzi,
Emilia Giugliano,
Marta Gubbiotti,
Monica Schippa,
Anna Marina Liberati
,
Giovanna Rege-Cambrin,
Carmen Fava,
Emilio Donti,
Debora Luzi,
Emilia Giugliano,
Marta Gubbiotti,
Monica Schippa,
Anna Marina Liberati
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 